The Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway is one of a handful of pleiotropic cascades used to transduce a multitude of signals for development and homeostasis in animals, from humans to flies. In mammals, the JAK/STAT pathway is the principal signaling mechanism for a wide array of cytokines and growth factors. JAK activation stimulates cell proliferation, differentiation, cell migration and apoptosis. These cellular events are critical to hematopoiesis, immune development, mammary gland development and lactation, adipogenesis, sexually dimorphic growth and other processes. Predictably, mutations that reduce JAK/STAT pathway activity affect these processes (reviewed by Igaz et al., 2001; O'Shea et al., 2002) . Conversely, mutations that constitutively activate or fail to regulate JAK signaling properly cause inflammatory disease, erythrocytosis, gigantism and an array of leukemias. Here we present a general overview of the JAK/STAT pathway and illustrate the primary mechanisms of activation and regulation of this essential signaling cascade.
Mechanistically, JAK/STAT signaling is relatively simple, with only a few principal components (for reviews, see Aaronson and Horvath, 2002; Heinrich et al., 2003; Kisseleva et al., 2002; O'Shea et al., 2002 
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Activation Inactivation
SOCS proteins are a family of at least eight members containing an SH2 domain and a SOCS box at the Cterminus (reviewed by Alexander, 2002 Jackson, 2001 ). Although there is evidence that STATs can be modified by sumoylation (Rogers et al., 2003) , the function of that modification in negative regulation is not yet known.
Although the mechanism of JAK/STAT signaling is relatively simple in theory, the biological consequences of pathway activation are complicated by interactions with other signaling pathways (reviewed by Heinrich et al., 2003; Rane and Reddy, 2000; Shuai, 2000) . An understanding of this crosstalk is only beginning to emerge, but the best characterized interactions of the JAK/STAT pathway are with the receptor tyrosine kinase (RTK)/Ras/ MAPK (mitogen-activated protein kinase) pathway. The relationship between these cascades is complex and their paths cross at multiple levels, each enhancing activation of the other. First, activated JAKs can phosphorylate tyrosines on their associated receptors that can serve as docking sites for SH2-containing adapter proteins from other signaling pathways. These include SHP-2 and Shc, which recruit the GRB2 adapter and stimulate the Ras cascade.
The same mechanism stimulates other cascades, such as the recruitment and JAK phosphorylation of insulin receptor substrate (IRS) and p85, which results in the activation of the phosphoinositide 3-kinase (PI3K) pathway [for more on PI3K signaling, see Foster et al. (Foster et al., 2003) ]. JAK/STAT signaling also indirectly promotes Ras signaling through the transcriptional activation of SOCS3. SOCS3 binds RasGAP, a negative regulator of Ras signaling, and reduces its activity, thereby promoting activation of the Ras pathway. Reciprocally, RTK pathway activity promotes JAK/STAT signaling by at least two mechanisms. First, the activation of some RTKs, including EGFR and PDGFR, results in the JAKindependent tyrosine phosphorylation of STATs, probably by the Src kinase. Second, RTK/Ras pathway stimulation causes the downstream activation of MAPK. MAPK specifically phosphorylates a serine near the Cterminus of most STATs. While not absolutely necessary for STAT activity, this serine phosphorylation dramatically enhances transcriptional activation by STAT. In addition to RTK and PI3K interactions with JAK/STAT signaling, multiple levels of cross-talk with the TGF-β signaling pathway have been recently reported [for a review of TGF-β, see (Moustakas, 2002) ]. Furthermore, the functions of activated STATs can be altered through association with other transcription factors and cofactors that are regulated by other signaling pathways. Thus the integration of input from many signaling pathways must be considered if we are to understand the biological consequences of cytokine stimulation.
The JAK/STAT pathway is ubiquitous amongst vertebrates, but can also be found as an intact pathway in some, but not all, other metazoans. A complete JAK/STAT signaling pathway required for an abundance of biological functions is found in Drosophila (for reviews, see Hombria and Brown, 2002; Zeidler et al., 2000) . There are single homologues for JAK, STAT and PIAS, as well as three SOCS homologues. Each of these components acts in the same fashion as its mammalian counterpart, although no mutants in the fly SOCS genes are yet available. Furthermore, there is a single JAK/STAT pathway receptor, Domeless, that shows weak similarities to the cytokine-binding modules of the vertebrate interleukin 6 (IL-6) receptor family. A predicted gene, CG14225, encodes a putative protein with similarity to Domeless, but no functional analyses have been reported. Only members of the Unpaired (Upd) family of secreted ligands, Upd and Upd3, have been shown to activate the JAK/STAT pathway in flies (Agaisse et al., 2003; Harrison et al., 1998) . Activation by a third homologue, Upd2, has yet to be reported. Although the Unpaireds bear no sequence similarity to cytokines, the predicted highly α-helical nature is consistent with an overall structure that could be similar to cytokines. Sequencing of the Drosophila genome has uncovered potential homologues of other JAK/STAT pathway molecules, including STAM, StIP and SH2-B/APS/Lnk family adapters. No mutations of these genes are yet available to test their function in JAK/STAT signaling. For some other organisms, such as C. elegans and Dictyostelium, there is not a complete functional JAK/STAT cassette, but homologues of some JAK/STAT pathway proteins can be found (Dearolf, 1999; Hombria and Brown, 2002) . For instance, STAT homologues in Dictyostelium are necessary for chemotaxis, prestalk cell movement during differentiation, and repression of stalk-specific genes. However, there are no JAKs in Dictyostelium, but rather STAT activation is mediated by Gprotein-coupled receptors (GPCRs) (reviewed by Williams, 2000) . Although the link is still controversial and the mechanism unclear, there is mounting evidence that GPCRs also signal through STATs in mammals. This potential commonality in mechanism suggests that portions of the JAK/STAT pathway may have arisen even prior to the appearance of metazoans. Genome sequences from additional organisms and mutants in identifiable homologues will greatly aid elucidation of the mechanism of evolution of the JAK/STAT signaling pathway.
